Skip to main content

Table 1 Summary of circRNAs in cancer

From: Circular RNAs in cancer: an emerging key player

Cancer name

CircRNA name

Expression level

Scope

Sample

Intersection molecules and/or pathway

References

Bladder carcinoma

circTCF25

Up

Bladder carcinoma vs normal

Tissues (n = 40)

miR-103a-3p,miR-107; circTCF25-miR-103a-3p/miR-107-CDK6

Zhong et al. [28]

cSCC

hsa_circ_0035381

Up

cSCC vs normal

Tissues (n = 12)

hsa-miR-124-5p,hsa-miR-9-5p

Sand et al. [32]

hsa_circ_0022383

Down

hsa-miR-124-5p

ESCC

cir-ITCH

Down

ESCC vs normal

Tissues (n = 684)

miR-7, miR-17, and miR-214;Wnt/β-catenin pathway

Li et al. [34]

Gastric cancer

has_circ_002059

Down

Gastric cancer vs normal

Tissues (n = 101)

–

Li et al. [23]

Plasma (n = 36)

CRC

hsa_circ_001988

Down

CRC vs normal

Tissues (n = 31)

–

Wang et al. [24]

cir-ITCH

Down

CRC vs normal

Tissues (n = 45)

Wnt/β-catenin pathway

Huang et al. [25]

HCC

hsa_circ_0001649

Down

HCC vs normal

Tissues (n = 89)

–

Qin et al. [26]

LSCC

hsa_circ_104912

Down

LSCC vs normal

Tissues (n = 52)

–

Xuan et al. [27]

hsa_circ_100855

Up

APL

f-circRNA

–

f-circRNA-expressing vas normal

Cells

PI3K and MAPK signal transduction pathways

Guarnerio et al. [29]

  1. Notes: Up upregulated, down downregulated
  2. Abbreviations: circRNAs circular RNAs, cSCC cutaneous squamous cell carcinoma, ESCC esophageal squamous cell carcinoma, CRC colorectal cancer, HCC hepatocellular carcinoma, LSCC laryngeal squamous cell cancer, APL acute promyelocytic leukemia